- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Siemens teams up with NYU Medical Center
NYU Medical Center has entered into a strategic alliance with Siemens Medical Solutions. The cornerstone of the alliance is a seven-year agreement that makes Siemens the exclusive supplier of the center's radiology imaging. The commercial value of the
NYU Medical Center has entered into a strategic alliance with Siemens Medical Solutions. The cornerstone of the alliance is a seven-year agreement that makes Siemens the exclusive supplier of the center's radiology imaging. The commercial value of the agreement will exceed $110 million, according to the company. The agreement covers approximately 100 advanced imaging systems, including a high-resolution research 7T MR scanner. Also included will be CTs, PET scanners, mammography, digital x-ray, and ultrasound equipment, as well as PACS. Due to the size and scope of the agreement, NYU and Siemens expect it will take four years to install all of the equipment and systems.
Another key aspect of the alliance is the commitment from both partners to MR imaging research. NYU plans to construct a new MR research facility near its midtown campus in Manhattan to house some of the new equipment, including the new 7T system, which will require a special room reinforced by some 300 tons of steel. Siemens will also install two 3T scanners dedicated to imaging research, particularly of the human brain, liver, kidneys, and prostate.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
